Approval · Notice of Compliance 7301 · 2005
SYNACTHEN DEPOT: Notice of Compliance 7301
Issued August 18, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7301
- Date
- August 18, 2005
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the product monograph
- Therapeutic class
- SYNTHETIC LONG-ACTING ß1-24 CORTICOTROPIN PEPTIDE
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SYNACTHEN DEPOT | Not yet assigned | — |
Medicinal ingredients
- COSYNTROPIN ZINC HYDROXIDE COMPLEX 1 MG per ML